All News
Filter News
Found 185 articles
-
Regeneron Reports First Quarter 2020 Financial and Operating Results
5/5/2020
Regeneron Pharmaceuticals, Inc. announced financial results for the first quarter of 2020 and provided a business update..
-
Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
2/6/2020
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the fourth quarter and full year 2019 and provided a business update.
-
Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton Award
11/22/2019
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that George D. Yancopoulos, M.D., Ph.D., Co-Founder, President and Chief Scientific Officer, was awarded Columbia College's Alexander Hamilton Medal, the highest honor awarded to a member of the Columbia College community for distinguished service and accomplishment in any field of endeavor.
-
Regeneron Reports Third Quarter 2019 Financial and Operating Results
11/5/2019
Regeneron Pharmaceuticals, Inc. announced financial results for the third quarter of 2019 and provided a business update..
-
Regeneron Ranked #2 in Science Magazine's Top Biopharma Companies to Work For
10/25/2019
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was once again ranked as a top company to work for by Science magazine in its annual Top Employers Survey of the global biotech and pharmaceutical industry.
-
Regeneron Colleagues Support 150 Community Organizations During Third Annual Day for Doing Good
10/25/2019
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today celebrates its third annual Day for Doing Good, a company-wide global day of service.
-
Regeneron Debuts on Prestigious Dow Jones Sustainability World Index of Most Sustainable Companies
9/17/2019
Regeneron Pharmaceuticals, Inc. announced that the company was added to the Dow Jones Sustainability World Index for the first time.
-
Regeneron Reports Second Quarter 2019 Financial and Operating Results
8/6/2019
Regeneron Pharmaceuticals, Inc. announced financial results for the second quarter of 2019 and provided a business update.
-
Harriet Schleifer Elected American Jewish Committee President
6/4/2019
Harriet Schleifer has been elected president of the American Jewish Committee, the leading global Jewish advocacy organization.
-
Shares of Regeneron fell more than 6 percent Tuesday after the company disclosed two deaths related to its vaunted bispecific antibody program.
-
Regeneron Reports First Quarter 2019 Financial and Operating Results
5/7/2019
Regeneron Pharmaceuticals, Inc. announced financial results for the first quarter of 2019 and provided a business update.
-
Sanofi and Regeneron, following Amgen dropping the price of Repatha in October 2018, have dropped Praluent to $5,850 a year. This is about a 60-percent reduction from the original price for both the 75 mg and 150 mg doses. The new prices will kick in early March.
-
Sanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list price
2/11/2019
This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients
-
Regeneron and Sanofi Offer Praluent® (alirocumab) at a New Reduced U.S. List Price
2/11/2019
This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients
-
Regeneron Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
2/6/2019
Regeneron Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year 2018 and provided a business update.
-
Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare Conference
1/7/2019
Regeneron Pharmaceuticals, Inc. will provide a strategic business update to the investor community at the 37th Annual J.P. Morgan Healthcare Conference
-
Toward the end of every year, biopharma executives are asked to dust off their crystal balls and predict what the next year might reveal. It’s that time of year again! Find out what execs are saying about M&A, gene therapy, sickle cell, and more.
-
In a survey of more than 8,000 people in the biotech and pharma industry for Science, Regeneron Pharmaceuticals, topped the list.
-
Regeneron Ranked #1 Biopharma Employer for Sixth Time by Science Magazine
10/26/2018
Company Also Celebrates Second Annual Global Day of Service.
-
“President Trump is taking historic action to bring patients more transparency through consumer advertising,” Azar said in a speech. “We are proposing to require American drug companies for the first time ever to include in their TV advertising the list prices of drugs paid for by Medicare or Med...